Andere Kunden interessierten sich auch für
![Novel Non-Pharmacological Approaches to Heart Failure, an Issue of Heart Failure Clinics]( "Novel Non-Pharmacological Approaches to Heart Failure, an Issue of Heart Failure Clinics")
Novel Non-Pharmacological Approaches to Heart Failure, an Issue of Heart Failure Clinics71,99 €![Emerging Comorbidities in Heart Failure, an Issue of Heart Failure Clinics]( "Emerging Comorbidities in Heart Failure, an Issue of Heart Failure Clinics")
Emerging Comorbidities in Heart Failure, an Issue of Heart Failure Clinics71,99 €![Genetics of Cardiomyopathy and Heart Failure, an Issue of Heart Failure Clinics]( "Genetics of Cardiomyopathy and Heart Failure, an Issue of Heart Failure Clinics")
Genetics of Cardiomyopathy and Heart Failure, an Issue of Heart Failure Clinics103,99 €![Process Improvement in Heart Failure, an Issue of Heart Failure Clinics]( "Process Improvement in Heart Failure, an Issue of Heart Failure Clinics")
Process Improvement in Heart Failure, an Issue of Heart Failure Clinics71,99 €![Biomarkers for Heart Failure, an Issue of Heart Failure Clinics]( "Biomarkers for Heart Failure, an Issue of Heart Failure Clinics")
Biomarkers for Heart Failure, an Issue of Heart Failure Clinics71,99 €![Valvular Heart Disease and Heart Failure, an Issue of Heart Failure Clinics]( "Valvular Heart Disease and Heart Failure, an Issue of Heart Failure Clinics")
Valvular Heart Disease and Heart Failure, an Issue of Heart Failure Clinics71,99 €![Hypertension: Pre-Hypertension to Heart Failure, an Issue of Cardiology Clinics]( "Hypertension: Pre-Hypertension to Heart Failure, an Issue of Cardiology Clinics")
Hypertension: Pre-Hypertension to Heart Failure, an Issue of Cardiology Clinics79,99 €
This issue of Heart Failure Clinics examines the pharmacologic approaches to heart failure: optimizing established therapy with a look toward future agents. Topics include the pathophysiologic foundation for the pharmacologic treatment of heart failure, treatment of heart failure with reducted ejection fraction and preserved ejection fraction, treatment of acute heart failure, investigational treatments, and the role of congestive heart failure medications following left ventricular assist device.